https://www.biospace.com/spectrum-pharmaceuticals-highlights-poziotinib-data-in-non-small-cell-lung-cancer-nsclc-presented-at-the-18th-iaslc-world-conference-on-lung-cancer-in-japan
Spectrum Pharmaceuticals Highlights Poziotinib Data In Non-Small-Cell Lung Cancer (NSCLC) Presented...
Oct 18, 2017 - Spectrum Pharma announced the oral presentation of interim data from a Phase 2 clinical study evaluating poziotinib in EGFR Exon 20 Mutant Non-Small-Cell Lung...
spectrum pharmaceuticalssmall celllung cancerhighlightspoziotinib